1. Home
  2. WMS vs CORT Comparison

WMS vs CORT Comparison

Compare WMS & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Advanced Drainage Systems Inc.

WMS

Advanced Drainage Systems Inc.

N/A

Current Price

$130.98

Market Cap

10.6B

ML Signal

N/A

Logo Corcept Therapeutics Incorporated

CORT

Corcept Therapeutics Incorporated

N/A

Current Price

$113.05

Market Cap

9.7B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
WMS
CORT
Founded
1966
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Containers/Packaging
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.6B
9.7B
IPO Year
2014
2001

Fundamental Metrics

Financial Performance
Metric
WMS
CORT
Price
$130.98
$113.05
Analyst Decision
Strong Buy
Buy
Analyst Count
8
5
Target Price
$180.63
$96.50
AVG Volume (30 Days)
656.6K
805.4K
Earning Date
05-21-2026
04-30-2026
Dividend Yield
0.49%
N/A
EPS Growth
N/A
N/A
EPS
2.19
0.09
Revenue
$3,050,376,000.00
$761,407,000.00
Revenue This Year
$5.23
$26.08
Revenue Next Year
$12.79
$26.98
P/E Ratio
$61.98
$1,259.44
Revenue Growth
5.03
12.79
52 Week Low
$128.03
$28.66
52 Week High
$179.32
$126.38

Technical Indicators

Market Signals
Indicator
WMS
CORT
Relative Strength Index (RSI) 34.25 51.71
Support Level $129.64 $77.73
Resistance Level $155.66 $122.21
Average True Range (ATR) 4.18 4.04
MACD -1.32 -1.68
Stochastic Oscillator 0.93 15.22

Price Performance

Historical Comparison
WMS
CORT

About WMS Advanced Drainage Systems Inc.

Advanced Drainage Systems Inc designs, manufactures and markets water management solutions in the stormwater and onsite wastewater industries, providing superior drainage solutions for use in the construction and agriculture markets. The company's products are used across a broad range of end markets and applications, including non-residential, residential, infrastructure and agriculture applications. It has two reportable segments: Stormwater and Wastewater. It derives the majority of revenue from the Stormwater segment, which manufactures and markets thermoplastic corrugated pipe and complementary products, including single wall pipe, N-12 HDPE pipe, polypropylene pipe, StormTech, Nyloplast, Inserta Tee, water quality filters and structures, and NDS channel drains, and access boxes.

About CORT Corcept Therapeutics Incorporated

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic, and neuropsychiatric disorders by modulating the effect of the cortisol hormone. The company markets Korlym (mifepristone) tablets and its authorized generic version, which is an oral medication for the treatment of hypercortisolism (also known as Cushing's syndrome). Additionally, its pipeline contains several key compounds, such as Relacorilant, Dazucorilant, Miricorilant, etc., that are being evaluated in clinical trials as potential treatments for a variety of serious disorders like hypercortisolism, solid tumors (including ovarian, endometrial, cervical, pancreatic, and prostate cancers), ALS, and MASH.

Share on Social Networks: